Literature DB >> 35536385

Spheroid culture models adequately imitate distinctive features of the renal cancer or melanoma microenvironment.

Aleksandra Filipiak-Duliban1,2, Klaudia Brodaczewska3, Aleksandra Majewska3,4, Claudine Kieda3,5.   

Abstract

Tumor development studies should adapt to cancer cells' specific mechanisms in connection with their microenvironment. Standard two-dimensional cultures and gas composition are not relevant to the real cancer environment. Existing three-dimensional models are often requiring sophisticated conditions. Here, we propose and characterize, in two cancer models, melanoma (B16F10) and kidney cancer (RenCa), a three-dimensional culture method, reporting the presence of hypoxia-related genes/proteins and aggressiveness mechanisms (epithelial mesenchymal transition and cancer stem cells). We validate the designed three-dimensional method by comparing it with in vivo growing tumors. The developed method brings simplicity and data reproducibility. Melanoma spheroid-growing cells reached a cell cycle arrest at the G0/G1 phase and showed induction of hypoxia. Spheroid-recovered RenCa cells were enriched in proliferating cells and displayed delayed hypoxia. Moreover, the responses to hypoxia observed in spheroids were validated by in vivo tumor studies for both lines. Three-dimensional shapes induced cancer stem cells in renal cancer, whereas epithelial to mesenchymal transition occurred in the melanoma model. Such distinction in the use of different aggressiveness-leading pathways was observed in in vivo melanoma vs kidney tumors. Thus, this 3D culture model approach is adequate to uncover crucial molecular pathways using distinct mechanisms to reach aggressiveness; i.e., B16F10 cells perform epithelial to mesenchymal transition while RenCa cells dedifferentiate into cancer stem cells. Such three-dimensional models help mimic the in vivo tumor features, i.e., hypoxia and aggressiveness mechanisms as validated here by next-generation sequencing analysis, and are proposed for further alternative methods to in vivo studies.
© 2022. The Society for In Vitro Biology.

Entities:  

Keywords:  3D; CSC; EMT; Melanoma; RCC

Mesh:

Year:  2022        PMID: 35536385     DOI: 10.1007/s11626-022-00685-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  49 in total

Review 1.  Mouse models of cancer.

Authors:  Dong-Joo Cheon; Sandra Orsulic
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

2.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

3.  Cell-Penetrating Peptide and α-Tocopherol-Conjugated Poly(amidoamine) Dendrimers for Improved Delivery and Anticancer Activity of Loaded Paclitaxel.

Authors:  Himanshu Bhatt; Balaram Ghosh; Swati Biswas
Journal:  ACS Appl Bio Mater       Date:  2020-04-28

4.  Generation of a 3D melanoma model and visualization of doxorubicin uptake by fluorescence imaging.

Authors:  Dora Domnica Baciu; Andrei Mihai Dumitrașcu; Valentin Vasile; Bianca Palade; Aurora Sălăgeanu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-01-03       Impact factor: 2.416

5.  HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.

Authors:  Jessica A Bertout; Amar J Majmundar; John D Gordan; Jennifer C Lam; Dara Ditsworth; Brian Keith; Eric J Brown; Katherine L Nathanson; M Celeste Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

Review 6.  Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells.

Authors:  Hasan Onur Caglar; Cigir Biray Avci
Journal:  Mol Biol Rep       Date:  2020-02-28       Impact factor: 2.316

Review 7.  Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia.

Authors:  Aude Carreau; Bouchra El Hafny-Rahbi; Agata Matejuk; Catherine Grillon; Claudine Kieda
Journal:  J Cell Mol Med       Date:  2011-06       Impact factor: 5.310

8.  Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133+ cells in clear cell renal carcinoma.

Authors:  John R Bradley; Jun Wang; Simon Pacey; Anne Y Warren; Jordan S Pober; Rafia S Al-Lamki
Journal:  FASEB Bioadv       Date:  2020-01-03

Review 9.  Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.

Authors:  Raefa Abou Khouzam; Klaudia Brodaczewska; Aleksandra Filipiak; Nagwa Ahmed Zeinelabdin; Stephanie Buart; Cezary Szczylik; Claudine Kieda; Salem Chouaib
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

10.  Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.

Authors:  Samuel Abourbih; Kanishka Sircar; Simon Tanguay; Wassim Kassouf; Armen Aprikian; Jose Mansure; Fadi Brimo
Journal:  World J Surg Oncol       Date:  2013-11-22       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.